REPEAT – Dorel Industries Will Hold a Conference Call to Discuss Its Second Quarter Results

(TSX:DII-B.TO),(TSX:DII-A.TO), MONTREAL, Aug. 07, 2025 (GLOBE NEWSWIRE) — Dorel Industries, Inc. (TSX: DII.B, DII.A) CONFERENCE CALL: OPEN TO: Analysts, investors and all interested parties DATE: Monday, August 11, 2025 TIME: 11:00 AM Eastern Time CALL: 1-833-752-3231 THE PRESS RELEASE WILL BE PUBLISHED THE FRIDAY PRIOR (AUGUST 8) AFTER MARKETS CLOSE, THROUGH GLOBENEWSWIRE. Please dial in […]

22nd Century Group to Announce Second Quarter 2025 Results on August 14, 2025

22nd Century Group to Announce Second Quarter 2025 Results on August 14, 2025 GlobeNewswire August 07, 2025 MOCKSVILLE, N.C., Aug. 07, 2025 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by

Champion Safe Co. Reports 30% Sales Growth with Northwest Safe — The Northwest’s Premier Retailer and a National Voice in Safe Security

Champion Safe Co. Reports 30% Sales Growth with Northwest Safe — The Northwest's Premier Retailer and a National Voice in Safe Security GlobeNewswire August 07, 2025 American Rebel Holdings, Inc. (NASDAQ: AREB) and Champion Safe Co. are committed to doing great business with top-tier partners who share our American values and proudly stand behind them

Disc Medicine Reports Second Quarter 2025 Financial Results and Provides Business Update

Disc Medicine Reports Second Quarter 2025 Financial Results and Provides Business Update GlobeNewswire August 07, 2025 Company on track to submit NDA for bitopertin in erythropoietic protoporphyria (EPP) under accelerated approval pathway in October 2025, supported by successful pre-NDA meeting Expect initial data from Phase 2 study of DISC-0974 in patients with anemia of myelofibrosis

Roadzen Onboards UK’s Leading Automotive Finance Broker, Motion Finance, to Deliver Embedded GAP Insurance for Vehicle Finance Customers

Roadzen Onboards UK's Leading Automotive Finance Broker, Motion Finance, to Deliver Embedded GAP Insurance for Vehicle Finance Customers GlobeNewswire August 07, 2025 NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) — Roadzen Inc. (Nasdaq: RDZN) (“Roadzen” or the “Company”), a global leader in AI at the intersection of insurance and mobility, today announced that its wholly

IperionX Granted Up to US$150 Million in Tax-Exempt Private Activity Bond Issuance Capacity

IperionX Granted Up to US$150 Million in Tax-Exempt Private Activity Bond Issuance Capacity GlobeNewswire August 07, 2025 CHARLOTTE, N.C., Aug. 07, 2025 (GLOBE NEWSWIRE) — IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX), a leading advanced materials company, has received a reservation of up to US$150 million in tax-exempt private activity bond (PAB) capacity from the

NRSInsights’ July 2025 Retail Same-Store Sales Report

NRSInsights' July 2025 Retail Same-Store Sales Report GlobeNewswire August 07, 2025 July same-store sales increased 5.8% year-over-year NEWARK, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) — NRSInsights, a provider of sales data and analytics drawn from retail transactions processed through the National Retail Solutions (NRS) point-of-sale (POS) platform, today announced comparative retail same-store sales results for

Golden Triangle Ventures Enters New Era with Strategic Restructuring and Market Expansion

Golden Triangle Ventures Enters New Era with Strategic Restructuring and Market Expansion GlobeNewswire August 07, 2025 LAS VEGAS, Aug. 07, 2025 (GLOBE NEWSWIRE) — via IBN — Golden Triangle Ventures, Inc. (OTC PINK: GTVH) (“GTVH” or the “Company”) is proud to announce a defining moment in its evolution — the execution of a binding Memorandum

Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies

Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies GlobeNewswire August 07, 2025 VERO BEACH, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies for cancer patients, today announced that it has secured a strategic investment and that it is

Alarum to Participate at the Canaccord Genuity 45th Annual Growth Conference on August 13, 2025

Alarum to Participate at the Canaccord Genuity 45th Annual Growth Conference on August 13, 2025 GlobeNewswire August 07, 2025 Presentation scheduled for Wednesday, August 13, 2025, at 8:30 a.m. ET Tel Aviv, Israel, Aug. 07, 2025 (GLOBE NEWSWIRE) — Alarum Technologies Ltd. (Nasdaq: ALAR, TASE: ALAR), a global provider of web data collection solutions, announced

Scroll to Top